544738-BOM

Speciality Medicines Ltd.

BSE: 544738

SME

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

189.95+1.9 (+1.04%)

8 Oct, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

70.1 / 100

Value Score

63.6 / 100

Price Momentum Score

2.2 / 100

QVM Score

36.0 / 100

Key Metrics

Market Cap

166.89

P/E (TTM)

12.81

P/B

2.34

P/S (TTM)

2.22

EV/EBITDA

10.89

CAPE (5Y)

29.86

ROE (TTM)

25.60

ROCE (TTM)

23.80

ROA (TTM)

19.27

Avg 3Y ROE

32.17

Earnings 3Y CAGR

97.61

Sales 3Y CAGR

47.96

Sales 5Y CAGR

Debt/Equity

0.09

Consensus TP

Strong Buy %

Promoter Holding

Pledged %

Stock Analysis

Fundamental analysis overview of Speciality Medicines Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is cheap and PE TTM is at a discount to industry median

PE TTM of 12.81 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -59.28%

What is P/E Ratio?

Median: 31.46

Value 12.81

-0.84732.63

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Weak price momentum

Price Momentum score of 2.2 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term

What is Price Momentum score?

2.2 / 100

Company's earnings are of low quality

Earnings quality score of 22.5 indicates that the company's earnings are of low quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

22.5 / 100

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Speciality Medicines Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Speciality Medicines Ltd. Shareholding Pattern

Quarterly breakdown of Speciality Medicines Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Dec 2025	Mar 2026
Total Promoter	-	43.43
Indian Promoter	-	43.43
Foreign Promoter	-	-
Institutions	-	0.24
Mutual Funds / UTI	-	-
FI/Bank/Insurance	0.00	0.00
Govt	-	-
FII	0.00	0.24
Other Institutions	0.00	0.00
Non-Institution	-	56.33
Bodies Corporate	-	1.06
Others (incl. Retail) No. of shareholders	0.00 0	55.27 741

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Speciality Medicines Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
Paradise Moon Investment Fund-I	04 Jun 2026	sell	₹ 211.00	60.00 k	-
Niraj Rajnikant Shah	04 Jun 2026	sell	₹ 210.00	50.00 k	-
Yash Hitesh Patel	29 May 2026	buy	₹ 207.85	2.00 lac	-
Niraj Rajnikant Shah	29 May 2026	buy	₹ 207.85	50.00 k	-
Feroza Anwar Shaikh	29 May 2026	sell	₹ 207.85	1.00 lac	-
Bhavna Hitesh Patel	29 May 2026	sell	₹ 225.52	5.00 k	-
Bhavna Hitesh Patel	29 May 2026	buy	₹ 208.42	69.00 k	-
Anwar Mohammed Shaikh	29 May 2026	sell	₹ 207.90	1.12 lac	-
Ainul Anwar Shaikh	29 May 2026	sell	₹ 207.85	1.02 lac	-
Neo Apex Share Broking Services Llp	22 May 2026	sell	₹ 208.95	61.00 k	-

No corporate action data available.

Company Profile

Overview of Speciality Medicines Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Speciality Medicines Limited is an India-based pharmaceutical company. The Company is engaged in marketing and distribution of finished formulations of specialty pharmaceuticals. It offers a diverse portfolio of specialty pharmaceuticals, focusing on therapeutic areas such as oncology, immunology, n...

Key personnel

Mr. Kalpesh Bharatbhai Pipaliya

Chief Financial Officer

Ms. Anita Kumawat

Compliance Officer, Company Secretary

Ms. Vandana Siyasharan Vashwakarma

Purchase Executive

Mr. Parthkumar Babulal GoyaniD

Executive Chairman of the Board, Managing Director

Mr. Sumit Babubhai GoyaniD

Whole Time Director

Mr. Bhaveshkumar Ashokbhai SavaniD

Non-Executive Director

Ms. Archana Madhav BhayaniD

Non-Executive Independent Director

Mr. Chandresh M. UnagarD

Non-Executive Independent Director

View all

Incorporated on

05 Feb 2021

Last Annual

31 Mar 2026

Last Interim

No. of Employees

IPO date

30 Mar 2026

Free Float

28,31,314

Website

https://www.specialitymedicine.com/

Phone no.

+912246045344

Address

27, First Floor, Andheri Sainath Industrial Premises Co-op-soc ltd, 20-Mahakali Caves Road, Andheri East, MUMBAI, 400093, India

Frequently Asked Questions

What is the current share price of Speciality Medicines Ltd.?

The current share price of Speciality Medicines Ltd. is ₹ 189.95 as of 8 Oct 2026.

What is the market capitalisation of Speciality Medicines Ltd.?

The market capitalisation of Speciality Medicines Ltd. stands at ₹ 166.89 Cr.

What is the PE ratio of Speciality Medicines Ltd.?

The Price-to-Earnings (PE) ratio of Speciality Medicines Ltd. is 12.81 as of the latest trailing twelve months data.

What is the ROE and ROCE of Speciality Medicines Ltd.?

Speciality Medicines Ltd. has a Return on Equity (ROE) of 25.60% and a Return on Capital Employed (ROCE) of 23.80% as per the latest financial reports.

What is the 52-week high and low of Speciality Medicines Ltd.?

The 52-week high of Speciality Medicines Ltd. is - and the 52-week low is -.

What is the dividend yield of Speciality Medicines Ltd.?

The dividend yield of Speciality Medicines Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Speciality Medicines Ltd.?

Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of Speciality Medicines Ltd. shares.

What sector does Speciality Medicines Ltd. belong to?

Speciality Medicines Ltd. operates in the Healthcare sector.

What is the beta of Speciality Medicines Ltd.?

The beta of Speciality Medicines Ltd. is -, indicating its price volatility relative to the broader market.

What is the RSI of Speciality Medicines Ltd.?

The 14-day Relative Strength Index (RSI) of Speciality Medicines Ltd. is 69.84, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Speciality Medicines Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Speciality Medicines Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile